Physician Urges FDA Shortage Declaration for Estrogen Patches
1 report, 1 independent
Updated Fri 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A physician requested the FDA declare a product shortage for estrogen patches used in hormone replacement therapy. Reports indicate that women across the country are facing obstacles filling prescriptions because local supplies are constantly fluctuating and many patches are on back order.
From wbtv.com
Why it matters
The shortage impacts the availability of HRT, which is used to reduce long-term risks such as cardiovascular disease and osteoporosis. Demand for these estrogen patches has climbed significantly, rising from 594,000 prescriptions in June 2024 to 1.6 million in May.
From wbtv.com
Who's involved
Possible ripples
Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.- Drug shortage pressure may force Congress to review FDA mandatesDrug shortage pressure may force Congress to review FDA mandatesPossible
- Governor Hobbs may face political pressure over drug shortage crisisGovernor Hobbs may face political pressure over drug shortage crisisPossible
- How could the physician petition urging FDA shortage declaration affect the Department of Health & Human Services?HHS may be forced to review drug shortage policy due to HRT supply issuesPossible